Position in KYTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,837,412
+$582,231 QoQ
Shares Held
212,910
+59.4% QoQ
Ownership
0.350%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. KYTX ranks #226 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in KYTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,837,412 | 212,910 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,255,181 | 133,530 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $258,792 | 43,132 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $418,680 | 136,378 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $201,607 | 104,460 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $424,392 | 113,474 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $390,235 | 79,803 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $467,175 | 62,290 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||